Largest biotech companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Gilead Sciences leads the 24 biotech companies ranked by net assets, at SGD 29.3B, ahead of BioNTech (SGD 27.5B) and Biogen (SGD 23.5B). Figures as of 18 Nov 2026, 19:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Gilead SciencesSGD 29.3B
- Median
- SGD 2.6B
- Combined market value
- SGD 1.08T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | SGD 29.3B | SGD 269.4B | SGD 217.20 | 1.09% down | 33% up | ||
| 2 | BioNTechBNTX · Health Care | SGD 27.5B | SGD 26.7B | SGD 107.87 | 1.44% down | 16% down | ||
| 3 | BiogenBIIB · Health Care | SGD 23.5B | SGD 47.7B | SGD 322.99 | 0.15% down | 49% up | ||
| 4 | AmgenAMGN · Health Care | SGD 11.2B | SGD 308.8B | SGD 570.88 | 3.34% down | 34% up | ||
| 5 | ModernaMRNA · Health Care | SGD 11.2B | SGD 103.9B | SGD 256.86 | 3.70% down | 755% up | ||
| 6 | argenxARGX · Health Care | SGD 9.4B | SGD 76.6B | SGD 1,218.58 | 0.29% down | 4% up | ||
| 7 | QiagenQGEN · Health Care | SGD 4.9B | SGD 13.2B | SGD 64.08 | 0.14% down | 12% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | SGD 4.2B | SGD 21.3B | SGD 210.53 | 1.62% down | 20% up | ||
| 9 | VaxcytePCVX · Health Care | SGD 3.5B | SGD 11.9B | SGD 75.23 | 1.80% down | 22% up | ||
| 10 | ExelixisEXEL · Health Care | SGD 2.8B | SGD 21.6B | SGD 88.60 | 0.28% up | 63% up | ||
| 11 | Bio-TechneTECH · Health Care | SGD 2.7B | SGD 14.7B | SGD 93.86 | 0.20% up | 26% up | ||
| 12 | RepligenRGEN · Health Care | SGD 2.7B | SGD 14.1B | SGD 220.33 | 5.33% up | 5% up | ||
| 13 | CRISPR TherapeuticsCRSP · Health Care | SGD 2.5B | SGD 5.1B | SGD 52.79 | 1.94% up | 21% down | ||
| 14 | Revolution MedicinesRVMD · Health Care | SGD 2.1B | SGD 44.8B | SGD 206.92 | 1.39% down | 131% up | ||
| 15 | Kymera TherapeuticsKYMR · Health Care | SGD 2B | SGD 13.4B | SGD 156.72 | 0.01% down | 87% up | ||
| 16 | Krystal BiotechKRYS · Health Care | SGD 1.6B | SGD 12B | SGD 403.91 | 4.89% up | 46% up | ||
| 17 | ImmunovantIMVT · Health Care | SGD 1.1B | SGD 8.9B | SGD 42.91 | 0.18% up | 43% up | ||
| 18 | CG OncologyCGON · Health Care | SGD 970.7M | SGD 9.1B | SGD 102.34 | 0.52% up | 85% up | ||
| 19 | Twist BioscienceTWST · Health Care | SGD 610M | SGD 10.4B | SGD 152.25 | 5.39% up | 340% up | ||
| 20 | Scholar Rock HoldingSRRK · Health Care | SGD 316.6M | SGD 7.5B | SGD 61.42 | 5.63% up | 14% up | ||
| 21 | Adaptive BiotechnologiesADPT · Health Care | SGD 282.2M | SGD 6B | SGD 36.81 | 0.18% up | 88% up | ||
| 22 | Kodiak SciencesKOD · Health Care | SGD 203M | SGD 8.2B | SGD 124.99 | 0.11% up | 396% up | ||
| 23 | Halozyme TherapeuticsHALO · Health Care | SGD 63M | SGD 14.2B | SGD 124.27 | 0.40% up | 37% up | ||
| 24 | ImmunityBioIBRX · Health Care | -SGD 645.5M | SGD 9.1B | SGD 8.54 | 5.83% up | 193% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2898 SGD).
Questions and answers
Which biotech companies rank first by net assets?
Gilead Sciences (SGD 29.3B), BioNTech (SGD 27.5B) and Biogen (SGD 23.5B) are the top three of the 24 biotech companies ranked by net assets as of 18 Nov 2026, 19:23 UTC.
How many biotech companies are in this ranking?
24 are ranked by net assets.
What are these biotech companies worth together?
The 24 biotech companies ranked by net assets have a combined market value of SGD 1.08T as of 18 Nov 2026, 19:23 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.